Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure

ISSN:
1432-1041
Keywords:
Key words Metoprolol ; Cardiomyopathy ; G-proteins; β-adrenoceptor density
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Medicine
Notes:
Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
Type of Medium:
Electronic Resource
URL:
_version_ 1798295571144900608
autor Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
autorsonst Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
book_url http://dx.doi.org/10.1007/s002280050172
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM202475883
issn 1432-1041
journal_name European journal of clinical pharmacology
materialart 1
notes Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
package_name Springer
publikationsjahr_anzeige 1996
publikationsjahr_facette 1996
publikationsjahr_intervall 8004:1995-1999
publikationsjahr_sort 1996
publisher Springer
reference 51 (1996), S. 127-132
schlagwort Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
search_space articles
shingle_author_1 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
shingle_author_2 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
shingle_author_3 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
shingle_author_4 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
shingle_catch_all_1 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
1432-1041
14321041
Springer
shingle_catch_all_2 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
1432-1041
14321041
Springer
shingle_catch_all_3 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
1432-1041
14321041
Springer
shingle_catch_all_4 Sigmund, M.
Jakob, H.
Becker, H.
Hanrath, P.
Schumacher, C.
Eschenhagen, T.
Schmitz, W.
Scholz, H.
Steinfath, M.
Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Key words Metoprolol
Cardiomyopathy
G-proteins; β-adrenoceptor density
Abstract Objective: In human heart failure downregulation of β-adrenoceptors and upregulation of Gi-protein α-subunits (Giα) results desensitization of the myocardial β-adrenergic signal transduction pathway and reduced positive inotropic effects of catecholamines. Metoprolol treatment has been shown to restore the reduced β-adrenoceptor density in dilated cardiomyopathy. The main objective of the present study was to investigate whether metoprolol also decreases the elevated inhibitory Giα levels in patients suffering from congestive heart failure. Methods: Total Giα was determined by pertussis toxin-catalysed ADP ribosylation and β1- and β2-adrenoceptor densities by radioligand binding in right ventricular myocardial biopsies of 18 patients with dilated or ischaemic cardiomyopathy (NYHA II–IV) before and after 3 months of therapy. Nine controls were treated with conventional therapy only [diuretics, digitalis, nitrates, angiotensin-converting enzyme (ACE) inhibitors], and nine received the β1-selective blocker metoprolol in addition (mean 98 ± 12 mg daily). Results: In biopsies from patients treated with metoprolol, Giα significantly decreased to 74% of predrug value and total β-adrenoceptor increased by a selective increase in β1- adrenoceptors (44.7 vs 34.0 fmol ⋅ mg−1 protein). These effects were accompanied by significantly increased oxygen uptake at the anaerobic threshold (8.65 vs 6.95 ml ⋅ kg−1⋅ min−1). In the control group no significant changes in biochemical and clinical parameters occurred. Conclusion: Metoprolol partly reverses Giα-upregulation and β-adrenoceptor downregulation in heart failure, which might contribute to the clinical improvement of patients treated with β-blockers.
1432-1041
14321041
Springer
shingle_title_1 Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
shingle_title_2 Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
shingle_title_3 Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
shingle_title_4 Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:38:19.155Z
titel Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
titel_suche Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
topic V
WW-YZ
uid nat_lic_papers_NLM202475883